MeVis Medical Solutions AG Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 2/1/2026)
| Balance Sheet | Total Assets | 25,886,400.00 | ROE | 68.86 % |
| Balance Sheet | Total Equity | 17,826,000.00 | ROA | 12.23 % |
| Cashflow | Capital Expenditures | -14,043,500.00 | P/FCF | -3.90 |
| Cashflow | Free Cash Flow | -10,164,384.00 | – | – |
| Cashflow | Operating Cash Flow | 3,879,100.00 | P/CF | 10.23 |
| Income | Earnings per Share (diluted) | 1.74 | Div. Yield | 5.18 % |
| Income | Net Income | 3,165,920.00 | P/E | 12.53 |
| Income | Shares Outstanding | 1,820,000.00 | P/B | 2.23 |
| Income | Total Revenue | 16,061,000.00 | P/S | 2.47 |
Ratios calculated on: 10/14/2026
Company Description
MeVis Medical Solutions AG develops, markets, and sells software for analyzing and evaluating image data to equipment manufacturers of medical devices and providers of medical IT platforms in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, prostate, and colon cancers, as well as neurological disorders. It operates in two segments, Digital Mammography and Other Diagnostics. The Digital Mammography segment develops and markets software products, which support breast diagnostic imaging and intervention. This segment also offers software applications for digital mammography, such as ultrasound, magnetic resonance imaging, and tomosynthesis. The Other Diagnostics segment provides digital radiology products, including magnetic resonance imaging and computer tomography for diseases, such as lung, prostate, and intestinal disorders, as well as general image-based analysis and diagnostics of radiology images. Its services are also used for lung diagnostics and general analysis of MR-image data; and technical visualization, which are used in training, for publication, presentations, and research purposes. This segment also provides interactive online training to enhance the diagnostic capabilities of clinical end customers. The company was founded in 1992 and is based in Bremen, Germany. MeVis Medical Solutions AG operates as a subsidiary of Varex Imaging Deutschland AG.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.mevis.de
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more